pulmonary hypertension + PE, DVT, pneumothorax Flashcards
(35 cards)
complications of pulmonary hypertension
arteriosclerosis
hypertrophy of media of pulmonary arteries
fibrosis of intima
cor pulmonale (right sided heart failure due to lung disease)
BMPR2: bone morphogenetic protein receptor type 2 mutation → ↑ vascular smooth muscle proliferation → reduced vessel radius, high resistance →↑ pulmonary arterial pressure
women around 36 yo
associated with HIV + karposi sarcoma (HHV-8)
primary pulmonary hypertension (idiopathic)
complication of chronic lung disease (COPD, pulmonary fibrosis): poor oxygenation → vasoconstriction
secondary to mitral stenosis: ↑ resistance →↑ back pressure to LA, pulmonary veins, caps, then pulm artery
recurrent thromboemboli
autoimmune disease
L-to-R shunt (VSD): right side can’t handle increase R sided pressure
sleep apnea or high altitude: hypoxic vasoconstriction
secondary pulmonary hypertension
purpose of BMPR2 protein
prevents proliferation of vascular smooth muscle
associated with HIV + karposi sarcoma (HHV-8)
primary pulmonary hypertension (idiopathic)
treatment of pulmonary hypertension
bosentan, ambrisentan
PG analog
sildenafil
nifedipine
substances that cause for methemoglobin (oxidized form of Hb - ferric, Fe3+)
nitrates and nitrites (had MI, give for chest pain while waiting for cath lab)
antimalarial drugs: chloroquine, primaquine
dapsone (AIDS patient)
sulfonamides (prevent pneumocystis pneumonia)
local anesthetics: lidocaine
metoclopramide
treatment for methemoglobinemia
acute: methylene blue, vitamin C
prevent: cimetidine (H2 blocker): gradually lowers level, use if on drugs that cause methemoglobin
what is virchow’s triad: ↑ risk of blood clots
1) stasis: post-op/bed rest, long trip (many hours), cast, paralyzed, pregnancy
2) hypercoagulability: sickle cell, polycythemia, congestive heart failure, estrogen excess, cancer, smoking (don’t give OCP >35 yo), pregnancy, OCP
3) endothelial damage: fracture, post-op, postpartum, bacterial infection, foreign bodies, surgery
examples: fractured bone in cast on bed rest (2), postpartum women after Csection (3)
venous return from lower extremities back to heart depends on
muscle contraction
valves in veins of legs
UNILATERAL foot/ankle edema or lower leg \+/- pain \+/- Homan sign \+/- palpable cord (vein) measure calf to see if swollen
DVT
homan sign
calf pain with ankle dorsiflexion with knee extended
not specific or sensitive for DVT (negative means nothing)
diagnosis of DVT
immediate compression US (if high probability: red, painful leg, hx of cancer, hypercoaguable risk factors)
D dimer then US if +D dimer (low probability)
prevention of DVT if in hypercoaguable state
heparin subq 2-3/day
LMWH: enoxaprin 1-2/day
compression stalkings or sequential compression device (SCD)
treatment of DVT
heparin + warfarin → stop heparin once warfarin is therapeutic
fibrin degradation product
elevated when plasmin is dissolving a clot
D-dimer
negative D dimer
r/o DVT or PE (sensitive test - good for screening)
complication of DVT
embolize → right heart → lung: PE
if patent foramen ovale → cross to left heart and enter brain: stroke
pleuritic chest pain + hypoxia (mimics MI)
SOB (common), cough, hemoptysis (rare)
fever
*tachypnea
*tachycardia
*AMS (less responsive, sick appearing)/confusion
if seen in any hospitalized pt: r/o PE
pulmonary embolism
saddle embolus =
sudden death
straddles bifurcation of pulmonary arteries→ no O2 blood
treatment of PE
normally: heparin/warfarin if massive (blocking pulmonary artery): thrombolysis (tPA, streptokinase, urokinase)
↑ D-dimer \+/- DVT on LE US normal CXR large A-a gradient on arterial blood gas (not profusing lung well) \+/- ECG changes (S1Q3T3) CT scan WITH CONTRAST: most common method of diagnosis if bad kidneys: V/Q scan pulmonary angiogram: invasive, not used
diagnosis of PE
S1Q3T3 EKG changes that may be seen in PE
lead 1: deep S
lead III: large Q, inverted T
V/Q scan
1) inhale radionucleide (ventilation phase) → see if any decreased uptake: pneumonia
2) during perfusion phase, inject contrast and see if any decreased uptake: PE